Showing results (81-90 of 150) with videos related to

Sort By:
Pageof 15
BMC Cancer|October 1, 2020
The evaluation of red blood cell folate and methotrexate levels during protocol M in childhood acute lymphoblastic leukemiaN Oosterom, M Fiocco, R Q H Kloos, et al.
Leukemia|March 30, 2011
Gene expression profiling in MDS and AML: potential and future avenuesK Theilgaard-Mönch, J Boultwood, S Ferrari, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2000
Expression and prognostic value of Wilms' tumor 1 and early growth response 1 proteins in nephroblastomaM A Ghanem, T H Van der Kwast, J C Den Hollander, et al.
Pediatric Blood & Cancer|December 30, 2014
Treatment of relapsed Wilms tumour (WT) patients: experience with topotecan. A report from the SIOP Renal Tumour Study Group (RTSG)A M C Mavinkurve-Groothuis, M M van den Heuvel-Eibrink, G A Tytgat, et al.
Cancer Chemotherapy and Pharmacology|January 23, 2021
Monitoring of EGFR mutations in circulating tumor DNA of non-small cell lung cancer patients treated with EGFR inhibitorsR B Verheijen, T T van Duijl, M M van den Heuvel, et al.
Bone|October 20, 2010
Germline variation in the MTHFR and MTRR genes determines the nadir of bone density in pediatric acute lymphoblastic leukemia: a prospective studyM L te Winkel, S M P F de Muinck Keizer-Schrama, R de Jonge, et al.
International Journal of Obesity (2005)|November 1, 2016
Efficacy and safety of bariatric surgery for craniopharyngioma-related hypothalamic obesity: a matched case-control study with 2 years of follow-upM Wijnen, D S Olsson, M M van den Heuvel-Eibrink, et al.
Molecular Cancer Research : MCR|May 7, 2015
EphB1 Suppression in Acute Myelogenous Leukemia: Regulating the DNA Damage Control SystemK R Kampen, F J G Scherpen, G Garcia-Manero, et al.
Endocrine Connections|August 14, 2024
Bone health in childhood low-grade glioma: an understudied problemI M A A van Roessel, J E Gorter, B Bakker, et al.
Leukemia|June 8, 2011
Prevalence and prognostic value of IDH1 and IDH2 mutations in childhood AML: a study of the AML-BFM and DCOG study groupsF Damm, F Thol, I Hollink, et al.
Pageof 15